Constitutive expression of HCA2 in human retina and primary human retinal pigment epithelial cells

Current Eye Research

Volumn 39, Issue 5, 2014, Pages 487-492

  Yu, Alice L ^a   Birke, Kerstin ^b   Lorenz, Reinhard L ^a   Welge Lussen, Ulrich ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

AMD; Diabetic retinopathy; Niacin maculopathy; Retina; RPE

Indexed keywords

G PROTEIN COUPLED RECEPTOR; MESSENGER RNA; PROTEIN HCA 2; UNCLASSIFIED DRUG; 3 HYDROXYBUTYRIC ACID; HCAR2 PROTEIN, HUMAN; NICOTINIC ACID; NICOTINIC RECEPTOR; PARAFFIN;

ARTICLE; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RETINA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ADULT; CELL LINE; CYTOLOGY; DIABETIC RETINOPATHY; EYEBANK; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; PRIMARY CELL CULTURE;

3-HYDROXYBUTYRIC ACID; ADULT; CELL LINE; DIABETIC RETINOPATHY; EYE BANKS; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NIACIN; PARAFFIN EMBEDDING; PRIMARY CELL CULTURE; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NICOTINIC; RETINAL PIGMENT EPITHELIUM; RNA, MESSENGER;

EID: 84898471388     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2013.848900     Document Type: Article

References (37)

1. Davenport AP, Anthony P, Sharman JL, Pawson AJ, Benson HE, Monaghan AE, et al. International Union of Basic and Clinical Pharmacology. LXXXVIII. G Protein-Coupled Receptor List: Recommendations for New Pairings with Cognate Ligands Pharmacol Rev 2013;65:967-986
2. Offermanns S. The nicotinic acid receptor GPR109A (HM74A or PUMA-G) as a new therapeutic target. Trends Pharmacol Sci 2006;27:384-390
3. Tunaru S, Kero J, Schaub A, Wufka C, Blaukat A, Pfeffer K, et al. (2003) PUMA-G and HM74 are receptors for nicotinic acid and mediate its antilipolytic effect. Nat Med 2003;9: 352-355
4. Wise A, Foord SM, Fraser NJ, Barnes AA, Elshourbagy N, Eilert M, et al. Molecular identification of high and low affinity receptors for nicotinic acid. J Biol Chem 2003;278: 9869-9874
5. Carlson LA. Nicotinic acid: The broad-spectrum lipid drug. A 50th anniversary review. J Intern Med 2005;258:94-114
6. Taggart AK, Kero J, Gan X, Cai TQ, Cheng K, Ippolito M, et al. (D)-beta-Hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-G. J Biol Chem 2005; 280:26649-26652
7. Maciejewski-Lenoir D, Richman JG, Hakak Y, Gaidarov I, Behan DP, Connolly DT. Langerhans cells release prostaglandin D2 in response to nicotinic acid. J Invest Dermatol 2006;126:2637-2646
8. Bermudez Y, Benavente CA, Meyer RG, Coyle WR, Jacobson MK, Jacobson EL. Nicotinic acid receptor abnormalities in human skin cancer: Implications for a role in epidermal differentiation. PLoS One 2011;6:e20487
9. Hanson J, Gille A, Zwykiel S, Lukasova M, Clausen BE, Ahmed K, et al. Nicotinic acid-And monomethyl fumarateinduced flushing involves GPR109A expressed by keratinocytes and COX-2-Dependent prostanoid formation in mice. J Clin Invest 2010;120:2910-2919
10. Benyó Z, Gille A, Kero J, Csiky M, Suchánková MC, Nüsing RM, et al. GPR109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushing. J Clin Invest 2005;115: 3634-3640
11. Benyó Z, Gille A, Bennett CL, Clausen BE, Offermanns S. Nicotinic acid-induced flushing is mediated by activation of epidermal langerhans cells. Mol Pharmacol 2006;70: 1844-1849
12. Martin PM, Ananth S, Cresci G, Roon P, Smith S, Ganapathy V. Expression and localization of GPR109A (PUMA-G/HM74A) mRNA and protein in mammalian retinal pigment epithelium. Mol Vis 2009;15:362-372
13. Rubic T, Trottmann M, Lorenz RL. Stimulation of CD36 and the key effector of reverse cholesterol transport ATPbinding cassette A1 in monocytoid cells by niacin. Biochem Pharmacol 2004;67:411-419
14. Duncan KG, Hosseini K, Bailey KR, Yang H, Lowe RJ, Matthes MT, et al. Expression of reverse cholesterol transport proteins ATP-binding cassette A1 (ABCA1) and scavenger receptor BI (SR-BI) in the retina and retinal pigment epithelium. Br J Ophthalmol 2009;93:1116-1120
15. Campochiaro PA, Jerdon JA, Glaser BM. The extracellular matrix of human retinal pigment epithelial cells in vivo and its synthesis in vitro. Invest Ophthalmol Vis Sci 1986; 27:1615-1621
16. Alge CS, Priglinger SG, Neubauer AS, Kampik A, Zillig M, Bloemendal H, et al. Retinal pigment epithelium is protected against apoptosis by alphaB-crystallin. Invest Ophthalmol Vis Sci 2002;43:3575-3582
17. Yu AL, Lorenz RL, Haritoglou C, Kampik A, Welge-Lussen U. Biological effects of native and oxidized low-Density lipoproteins in cultured human retinal pigment epithelial cells. Exp Eye Res 2009;88:495-503
18. Leschey KH, Hackett SF, Singer JH, Campochiaro PA. Growth factor responsiveness of human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 1990;31:839-846
19. Welge-Lüssen U, May CA, Eichhorn M, Bloemendal H, Lutjen-Drecoll E. aB-crystallin in the trabecular meshwork is inducible by transforming growth factor-b. Invest Ophthalmol Vis Sci 1999;40:2235-2241
20. Li X, Millar JS, Brownell N, Briand F, Rader DJ. Modulation of HDL metabolism by the niacin receptor GPR109A in mouse hepatocytes. Biochem Pharmacol 2010;80: 1450-1457
21. Gambhir D, Ananth S, Veeranan-Karmegam R, Elangovan S, Hester S, Jennings E, et al. GPR109A as an antiinflammatory receptor in retinal pigment epithelial cells and its relevance to diabetic retinopathy. Invest Ophthalmol Vis Sci 2012;53:2208-2217
22. Wanders D, Judd RL. Future of GPR109A agonists in the treatment of dyslipidaemia. Diabetes Obes Metab 2011;13: 685-691
23. Plaisance EP, Lukasova M, Offermanns S, Zhang Y, Cao G, Judd RL. Niacin stimulates adiponectin secretion through the GPR109A receptor. Am J Physiol Endocrinol Metab 2009;296:549-558
24. Costagliola C, Daniele A, dell'Omo R, Romano MR, Aceto F, Agnifili L, et al. Aqueous humor levels of vascular endothelial growth factor and adiponectin in patients with type 2 diabetes before and after intravitreal bevacizumab injection. Exp Eye Res 2013;110:50-54
25. Ganapathy V, Ramamoorthy JD, Del Monte MA, Leibach FH, Ramamoorthy S. Cyclic AMP-Dependent up-regulation of the taurine transporter in a human retinal pigment epithelial cell line. Curr Eye Res 1995;14:843-850
26. Canner PL, Berge KG, Wenger NK, Stamler J, Friedman L, Prineas RJ, et al. Fifteen year mortality in Coronary Drug Project patients: Long-Term benefit with niacin. J Am Coll Cardiol 1986;8:1245-1255
27. Lukasova M, Malaval C, Gille A, Kero J, Offermanns S. Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cells. J Clin Invest 2011;121:1163-1173
28. Robman L, McNeil J, Dimitrov P, Dowrick A, Tikellis G, Nicolas C, et al. Methodology of the Cardiovascular Health and Age-Related Maculopathy (CHARM) Study. Ophthalmic Epidemiol 2004;11:161-179
29. Vingerling JR, Dielemans I, Bots ML, Hofman A, Grobbee DE, de Jong PT. Age-related macular degeneration is associated with atherosclerosis. The Rotterdam Study. Am J Epidemiol 1995;142:404-409
30. Guymer RH, Dimitrov PN, Varsamidis M, Lim LL, Baird PN, Vingrys AJ, et al. Can HMG Co-A reductase inhibitors (''statins'') slow the progression of age-related macular degeneratioñ The age-related maculopathy statin study (ARMSS). Clin Interv Aging 2008;3:581-593
31. Mares-Perlman JA, Brady WE, Klein R, VandenLangenberg GM, Klein BE, Palta M. Dietary fat and age-related maculopathy. Arch Ophthalmol 1995;113:743-748
32. Tan JS, Mitchell P, Smith W, Wang JJ. Cardiovascular risk factors and the long-Term incidence of age-related macular degeneration: The Blue Mountains Eye Study. Ophthalmology 2007;114:1143-1150
33. Bora PS, Kaliappan S, Lyzogubov VV, Tytarenko RG, Thotakura S, Viswanathan T, Bora NS. Expression of adiponectin in choroidal tissue and inhibition of laser induced choroidal neovascularization by adiponectin. FEBS Lett 2007;581:1977-1982
34. Gass JD. Nicotinic acid maculopathy. 1973. Retina 2003;23: 500-510
35. Millay RH, Klein ML, Illingworth DR. Niacin maculopathy. Ophthalmology 1988;95:930-936
36. Jampol LM. Niacin maculopathy. Ophthalmology 1988;95: 1704-1705
37. Tachikawa M, Murakami K, Martin PM, Hosoya K, Ganapathy V. Retinal transfer of nicotinate by H-monocarboxylate transporter at the inner blood-retinal barrier. Microvasc Res 2011;82:385-390